While we do our utmost to offer good advice and information we cannot be held responsible ... on or linked to the newsrooms or news coverage. Terms apply, see operator site for Terms and Conditions.

The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.

NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ET ...

The Consumer Financial Protection Bureau has been a go-to financial agency for dealing with bad practices. Trump ...

Operator Greetings, and welcome to the Aurora Cannabis Inc. third quarter 2025 results conference call. [Operator ...

Plus: Trump tariffs, beneficial ownership information (BOI) reporting, Earned Income Tax Credit, student loan interest ...

OGI earnings call for the period ending December 31, 2024. Organigram ( OGI -13.84%) Q1 2025 Earnings Call Feb 11, 2025, 8:00 ...

The Company's fourth fiscal quarter 2024 net earnings attributable to VPG stockholders were $0.8 million, or $0.06 per ...

Q4 2024 Earnings Call Transcript February 11, 2025 Leidos Holdings, Inc. beats earnings expectations. Reported EPS is $2.37, expectations were $2.24. Operator: Greetings. Welcome to Leidos Fourth ...

Be sure to include credit card debt, medical ... institution's Terms and Conditions. Pre-qualified offers are not binding. If you find discrepancies with your credit score or information from ...